Hematoma Block for Distal Radius Fracture
Beth Israel Deaconess Medical Center · with Harvard University · NCT02346929
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 115
- US sites recruiting
- 1
- Study start
- August 2014
- Record last updated
- March 3, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to determine the efficacy of ultrasound guided hematoma block versus traditional "blind" hematoma block for analgesia in distal radius fracture reduction.
Being studied: ultrasound guide
Conditions: Distal Radius Fracture
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adult patient ≥ 18 years old presenting to the emergency department with complaint of distal radius fracture
Exclusion Criteria
- High acuity/distress per the Attending ED physician
- Altered mental status or intoxication
- Aphasia, mental retardation, dementia, or insurmountable communication barrier
- Acute psychiatric illness
Recruiting US locations
Beth Israel Deaconess Medical Center
Boston, MA 02215
Site contact: Beatrice Hoffmann, MD · 617-754-2323 · bhoffma2@bidmc.harvard.edu
Study contacts (from the official record)
- Beatrice Hoffmann, MD · 617-754-2323 · bhoffma2@bidmc.harvard.edu
- Nathan I Shapiro, MD MPH · 617-754-2332 · nshapiro@bidmc.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+